CF
AZN icon

Centaurus Financial’s AstraZeneca AZN Stock Holding History

Centaurus Financial’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$607K Buy
3,203
+151
+5% +$28.4K 0.02% 531
2026
Q1 		$602K Sell
3,052
-258
-8% -$49.7K 0.03% 472
2025
Q4 		$609K Sell
3,310
-400
-11% -$70.2K 0.03% 467
2025
Q3 		$569K Buy
3,710
+183
+5% +$27.7K 0.03% 492
2025
Q2 		$493K Sell
3,527
-125
-3% -$17.5K 0.03% 482
2025
Q1 		$537K Buy
3,652
+498
+16% +$72.1K 0.03% 435
2024
Q4 		$413K Buy
3,154
+1,135
+56% +$159K 0.03% 490
2024
Q3 		$315K Buy
2,019
+850
+73% +$137K 0.02% 523
2024
Q2 		$182K Buy
+1,169
New +$176K 0.01% 627
2023
Q2 		– Sell
-1,028
Closed -$143K – 753
2023
Q1 		$143K Sell
1,028
-3
-0.3% -$404 0.01% 755
2022
Q4 		$140K Sell
1,031
-22
-2% -$2.76K 0.01% 696
2022
Q3 		$115K Sell
1,053
-485
-32% -$61.5K 0.01% 760
2022
Q2 		$203K Sell
1,538
-203
-12% -$26.6K 0.02% 605
2022
Q1 		$231K Sell
1,741
-1,510
-46% -$181K 0.02% 626
2021
Q4 		$379K Sell
3,251
-235
-7% -$27.7K 0.03% 514
2021
Q3 		$419K Sell
3,486
-182
-5% -$21.2K 0.04% 461
2021
Q2 		$439K Sell
3,668
-625
-15% -$68.6K 0.04% 462
2021
Q1 		$427K Sell
4,293
-3,930
-48% -$395K 0.04% 410
2020
Q4 		$822K Buy
8,223
+676
+9% +$71.6K 0.09% 265
2020
Q3 		$827K Buy
7,547
+5,391
+250% +$600K 0.11% 199
2020
Q2 		$228K Buy
+2,156
New +$223K 0.03% 395
2018
Q3 		– Sell
-3,961
Closed -$278K – 651
2018
Q2 		$278K Buy
+3,961
New +$285K 0.04% 435

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Centaurus Financial's AZN Position: Q2 2026 in Review

Centaurus Financial increased its AstraZeneca (AZN) stake by 4.9% in Q2 2026, buying an estimated $28.4K and bringing the position to 3,203 shares worth $607K. The position accounts for 0.02% of the portfolio, ranked #531.

Centaurus Financial first reported a position in AZN in Q2 2018 and has held it in 22 quarters since. The position peaked at $827K in Q3 2020. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Centaurus Financial held 3,203 shares of AstraZeneca worth $607K as of Q2 2026.
  • Centaurus Financial bought 151 AstraZeneca shares in Q2 2026, an estimated $28.4K.
  • AstraZeneca made up 0.02% of Centaurus Financial's portfolio in Q2 2026, its #531 holding.
  • Centaurus Financial first reported a position in AstraZeneca in Q2 2018 and has held it in 22 quarters since.
  • Centaurus Financial's AstraZeneca position peaked at $827K in Q3 2020.
  • 1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Centaurus Financial's 13F filing for Q2 2026, filed 17 Aug 2026.